>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance
:
  • INTT +30.6%, (very thinly traded), COGT +16.4%, ESES +12.7%, CVGI +6.7%, CDXS +5.4%, (light volume)
  • ZGNX +5.2%, ABTL +5.2%, VCEL +5.2%, MYRG +5.1%, PVG +4.3%
  • TEAR +4%, (also confirms plans to explore strategic alternatives), WLDN +4%, GST +3.5%
  • MTN +1.7%, OCUL +1.6%, ZFGN +1.3%, ACTG +0.9%
M&A news:
  • BT +3.6% (BT Group plc and OFCOM reach agreement on future governance of Openreach; to be a legally separate company within BT with its own Board)
  • BP +2.1% (The UK's Evening Standard reports on market rumors that Exxon Mobil (XOM) has reached out to large BP shareholders regarding a potential acquisition)
Select financial related names showing strength:
  • DB +2.7%, ING +2.5%, SAN +1.6%, CS +1.6%, BAC +1.1%, C +0.9%, LYG +0.9%
Other news:
  • SPWR +7.2% (puts 100MW Chilean solar plant up for sale, according to Reuters)
  • CRIS +5.5% (continued strength)
  • PRKR +3.3% (completes sale of approx. 4.1 mln of its common stock at $2.46/shareg)
  • SKLN +2.8% (light volume, schedules call to provide business update and discuss recent/upcoming milestones for March 15 at 4:30pm ET)
  • CLF +2.2% (announces increase in maximum payment amount with respect to tender offers for certain of its unsecured notes)
  • VRX +1.6% (prices notes offering)
  • BCRX +1.3% (prices offering of 5,294,118 shares of its common stock at $8.50 per share)
  • ACOR +1% (announces the PTAB has upheld four Ampyra patents)
Analyst comments:
  • SRRA +8.4% (upgraded to Buy from Hold at SunTrust)
  • INAP +5.3% (upgraded to Buy from Hold at Stifel)
  • TTPH +3.6% (upgraded to Outperform from Market Perform at BMO Capital)
  • VIP +3% (initiated with a Buy at ING Group)
  • ASML +2.1% (upgraded to Buy from Neutral at UBS)
  • HIMX +2.1% (upgraded to Equal-Weight from Underweight at Morgan Stanley)
  • ABBV +1% (added to Conviction Buy List at Goldman)
  • YUM +0.8% (upgraded to Outperform from In-line at Evercore ISI)